A Randomized, Crossover Study To Evaluate The Efficacy Of Inhaled Iloprost On Dynamic Hyperinflation And Exercise Tolerance In Patients With Chronic Obstructive Pulmonary Disease Irrespective Of Pulmonary Hypertension.

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 13 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Iloprost (Primary)
Indications Chronic obstructive pulmonary disease
Focus Therapeutic Use

Most Recent Events

24 May 2017 Results of influence of inhaled iloprost on subset of patients from this ongoing study presented at the 113th International Conference of the American Thoracic Society
24 May 2017 Results (n=12) of secondary analysis assessing the impact of exercise on c-myomiR expression, presented at the 113th International Conference of the American Thoracic Society
18 Aug 2015 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight